Astrazeneca Plc (AZN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 12,024,000 | 11,492,000 | 11,416,000 | 10,879,000 | 11,207,000 |
| Cost of Goods | 2,308,000 | 2,095,000 | 1,960,000 | 1,905,000 | 2,900,000 |
| Gross Profit | 9,716,000 | 9,397,000 | 9,456,000 | 8,974,000 | 8,307,000 |
| Operating Expenses | 8,482,000 | 7,443,000 | 7,000,000 | 6,666,000 | 7,978,000 |
| Operating Income | 1,234,000 | 1,954,000 | 2,456,000 | 2,308,000 | 329,000 |
| Interest Expense | 445,000 | 392,000 | 431,000 | 365,000 | 344,000 |
| Other Income | 108,000 | 90,000 | 63,000 | 319,000 | 793,000 |
| Pre-tax Income | 897,000 | 1,652,000 | 2,088,000 | 2,262,000 | 778,000 |
| Income Tax | -62,000 | 274,000 | 268,000 | 458,000 | -124,000 |
| Net Income Continuous | 959,000 | 1,378,000 | 1,820,000 | 1,804,000 | 902,000 |
| Minority Interests | 1,000 | -4,000 | -2,000 | -1,000 | -1,000 |
| Net Income | $960,000 | $1,374,000 | $1,818,000 | $1,803,000 | $901,000 |
| EPS Basic Total Ops | 0.62 | 0.89 | 1.17 | 1.16 | 0.58 |
| EPS Basic Continuous Ops | 0.62 | 0.89 | 1.17 | 1.16 | 0.58 |
| EPS Diluted Total Ops | 0.62 | 0.88 | 1.17 | 1.16 | 0.58 |
| EPS Diluted Continuous Ops | 0.62 | 0.88 | 1.17 | 1.16 | 0.58 |
| EBITDA(a) | $2,216,000 | $3,326,000 | $3,795,000 | $4,129,000 | $2,376,000 |